This inventor holds 1 USPTO granted patent. Top assignee: Ucl Business Plc. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of John Francis Martin
Introduction
John Francis Martin is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic applications, particularly with his innovative work involving tetrathiomolybdate. His research focuses on conditions that require reduced metabolism of an organ or the whole body, such as myocardial infarction, stroke, or ischaemia-reperfusion injury.
Latest Patents
John Francis Martin holds a patent for the therapeutic use of tetrathiomolybdate. This patent addresses the need for effective treatments in critical medical conditions, showcasing his commitment to advancing healthcare solutions. He has 1 patent to his name, reflecting his innovative approach to medical therapy.
Career Highlights
Martin is associated with UCL Business Plc, where he continues to develop and refine his ideas. His work has the potential to impact many lives, particularly those suffering from serious health conditions. His dedication to research and innovation is evident in his contributions to the medical field.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues such as Mervyn Singer and Alex Peter Dyson. These partnerships have likely enriched his research and expanded the scope of his work in therapeutic applications.
Conclusion
John Francis Martin exemplifies the spirit of innovation in the medical field through his work on tetrathiomolybdate. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
